Olympus Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Olympus Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1932
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Olympus Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Olympus Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Olympus Corporation (Olympus or ‘the company’) is engaged in the manufacturing and marketing of precision machineries and devices for medical, imaging, life science and industrial applications. The company’s product portfolio includes video endoscopy systems, gastrointestinal endoscopes, colono endoscopes, industrial fiberscopes, life science imaging software, virtual slide systems, bio-imaging systems, capsule endoscope systems, reprocessing products for cleaning, disinfection and sterilization. It further offers microscopic 3D measurement instruments, and industrial microscope ancillary equipment, stereo microscopes, digital camera accessories, software and applications, lens barrel units and binoculars among others. The company operates in Japan, Asia and Oceania, North America and Europe. Olympus is headquartered in Tokyo, Japan.

Scope

- Detailed information on Olympus Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Olympus Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Olympus Corporation including a breakdown and examination of key business segments
- Intelligence on Olympus Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Olympus Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Olympus Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Olympus Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Olympus Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Olympus Corporation: Company Overview 9
Olympus Corporation: Overview and Key Facts 9
Olympus Corporation: Overview 9
Olympus Corporation: Key Facts 9
Olympus Corporation: Key Employees 11
Olympus Corporation: Key Employee Biographies 13
Olympus Corporation: Major Products and Services 14
Olympus Corporation: Company History 16
Olympus Corporation: Management Statement 26
Olympus Corporation: Key Competitors 27
Olympus Corporation: Company Analysis 28
Olympus Corporation: Business Description 28
Olympus Corporation: SWOT Analysis 30
Olympus Corporation: SWOT Overview 30
Olympus Corporation: Strengths 30
Olympus Corporation: Weaknesses 31
Olympus Corporation: Opportunities 31
Olympus Corporation: Threats 32
Olympus Corporation: Corporate Financial Deals Activity 34
Olympus Corporation: Financial Deals Overview 34
Olympus Corporation: Targets and Partners 36
Olympus Corporation: Top Deals 2014 – 2018YTD* 37
Olympus Corporation: Advisors 38
Olympus Corporation: Top Financial Advisors 38
Olympus Corporation: Mergers and Acquisitions 39
Olympus Corporation: Capital Raising 40
Olympus Corporation: Partnership 41
Olympus Corporation: Divestments 42
Olympus Corporation: Recent Developments 43
Olympus Corporation: News and Events Summary 43
Olympus Corporation: Business Expansion 47
Olympus Corporation: Contracts 48
Olympus Corporation: Corporate Governance 50
Olympus Corporation: Grants 50
Olympus Corporation: Regulatory and Legal Events 51
Olympus Corporation: Strategy and Operations 52
Appendix 53
Contact Us 53
Methodology 53
About MarketLine 54

List of Tables
Table 1: Olympus Corporation: Key Facts
Table 2: Olympus Corporation: Key Employees
Table 3: Olympus Corporation: Key Competitors
Table 4: Olympus Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Olympus Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Olympus Corporation: Targets and Partners
Table 7: Olympus Corporation: Top Deals 2014 - 2018YTD*
Table 8: Olympus Corporation: Financial Advisor Ranking by Value (US$m)
Table 9: Olympus Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Olympus Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: Olympus Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: Olympus Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Olympus Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Olympus Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Olympus Corporation: Divestments by Geography (2014 - YTD*2018)
Table 16: Olympus Corporation: News and Events Summary
Table 17: Olympus Corporation: Business Expansion
Table 18: Olympus Corporation: Contracts
Table 19: Olympus Corporation: Corporate Governance
Table 20: Olympus Corporation: Grants
Table 21: Olympus Corporation: Regulatory and Legal Events
Table 22: Olympus Corporation: Strategy and Operations

List of Figures
Figure 1: Olympus Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Olympus Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Olympus Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Olympus Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: Olympus Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 6: Olympus Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Olympus Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Olympus Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Olympus Corporation: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Olympus Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MPI Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MPI Research Inc (MPI) is a drug development contract research organization that offers contracted scientific research services. The organization’s services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services and medical devi …
  • Intuit Inc.:企業の戦略・SWOT・財務分析
    Intuit Inc. - Strategy, SWOT and Corporate Finance Report Summary Intuit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bellerophon Therapeutics Inc (BLPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Neo Performance Materials Inc:企業の戦略・SWOT・財務分析
    Neo Performance Materials Inc - Strategy, SWOT and Corporate Finance Report Summary Neo Performance Materials Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Shamrock Foods Company:企業の戦略的SWOT分析
    Shamrock Foods Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Leidos Holdings Inc:企業の戦略・SWOT・財務情報
    Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cegedim SA (CGM):企業の財務・戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is a technology company that offers healthcare technical services. The company offers solutions to facilitate business and medical operations. It offers health and preventive health management software used in management of individual and collective health and preventive …
  • Nestle SA:企業のM&A・事業提携・投資動向
    Nestle SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nestle SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Mission Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mission Therapeutics Ltd (Mission) is a provider of deubiquitylating enzyme drug discovery and development programs. The company develops USP30, USP10 and UHCL1 for patients with mitochondria diseases, neurodegeneration, inflammation and others. the company uses its proprietaryDUB platform t …
  • R. R. Donnelley & Sons Co (RRD):企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Gibson Energy Inc (GEI)-石油・ガス分野:企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • U.S. Department of Veterans Affairs-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Department of Veterans Affairs (DVA) is a healthcare organization that provides benefit management and veteran services. The organization provides general benefits information, disability compensation, pension, GI bill, vocational rehabilitation and employment, vet success, educational …
  • Stobart Group Limited (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Limited (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Orphazyme AS (ORPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Orphazyme A/S (Orphazyme) formerly Orphazyme ApS, is a biopharmaceutical company that develops heat shock protein based therapies for the treatment of orphan protein-misfolding diseases. Its lead product drug candidate arimoclomol is under clinical development for treating neuromuscular dise …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ambry Genetics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …
  • Science Applications International Corp:企業の戦略・SWOT・財務分析
    Science Applications International Corp - Strategy, SWOT and Corporate Finance Report Summary Science Applications International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆